Skip to main content
Premium Trial:

Request an Annual Quote

Brian Osborne, Severin Schwan, Franz Humer, Dan Stoicescu

Premium
Brian Osborne has joined BioTeam as a principal investigator, the Boston-based company said last week. He will help clients with “challenges in high performance computing, informatics, and next-generation sequencing,” according to the company. Osborne comes to BioTeam from his own consulting company, ZBIO. Prior to that, he was both CTO and director of informatics at Cognia, and director of IT at OSI Pharmaceuticals. Previously, he was also group leader for bioinformatics at Cadus Pharmaceuticals and worked in the plant genome sequencing lab at the University of California, Berkeley. Osborne holds a PhD in biology from the Massachusetts Institute of Technology and a bachelor’s degree from Hampshire College.
 

 
Severin Schwan took over as CEO of Roche at the company’s annual general meeting this week. He succeeds Franz Humer. Schwan, who was previously CEO of Roche Diagnostics, a division of Roche, had been scheduled to become Roche’s CEO since last fall.
 

 
Dan Stoicescu has become the second customer of Cambridge, Mass.-based personal genome sequencing startup Knome, according to an article in the New York Times this week. He is the founder of Sindan, a company based in Bucharest, Romania, holds a PhD in medicinal chemistry, and lives in Switzerland, according to the article.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.